The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation study

被引：0
|
作者：
Toni Roeke
Marcelo Sobral-Leite
Tim J. A. Dekker
Jelle Wesseling
Vincent T. H. B. M. Smit
Rob A. E. M. Tollenaar
Marjanka K. Schmidt
Wilma E. Mesker
机构：
[1] Leiden University Medical Centre,Department of Surgery
[2] Netherlands Cancer Institute,Division of Molecular Pathology
[3] Leiden University Medical Centre,Department of Pathology
来源：
Breast Cancer Research and Treatment | 2017年 / 166卷
关键词：
Breast cancer; Tumour; Stroma; Survival; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：435 / 445
页数：10
相关论文
共 50 条
  • [21] Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
    Smit, Marloes A.
    van Pelt, Gabi W.
    Terpstra, Valeska
    Putter, Hein
    Tollenaar, Rob A. E. M.
    Mesker, Wilma E.
    van Krieken, J. Han J. M.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (12) : 2729 - 2737
  • [22] Tumour microenvironment: tumour-stroma ratio and cancer-associated fibroblasts
    Souza da Silva, R. M.
    Pedra Dias, E.
    VIRCHOWS ARCHIV, 2019, 475 : S210 - S210
  • [23] Tumour-stroma ratio: a strong and independent prognostic factor for adenocarcinomas of the esophagus
    Wouters, M.
    Takkenberg, M.
    Mesker, W.
    Smit, V.
    Stassen, L.
    Hartgrink, H.
    Tollenaar, R.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 57 - 57
  • [24] Prognostic significance of tumour stroma ratio in inflammatory breast cancer
    Downey, Candice L.
    Thygesen, Helene H.
    Sharma, Nisha
    Shaaban, Abeer M.
    SPRINGERPLUS, 2015, 4
  • [25] The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
    C. J. H. Kramer
    K. M. H. Vangangelt
    G. W. van Pelt
    T. J. A. Dekker
    R. A. E. M. Tollenaar
    W. E. Mesker
    Breast Cancer Research and Treatment, 2019, 173 : 55 - 64
  • [26] Tumour-stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case-cohort study
    Dang, Hao
    van Pelt, Gabi W.
    Haasnoot, Krijn J. C.
    Backes, Yara
    Elias, Sjoerd G.
    Seerden, Tom C. J.
    Schwartz, Matthijs P.
    Spanier, Bernhard W. M.
    de Vos tot Nederveen Cappel, Wouter H.
    van Bergeijk, Jeroen D.
    Kessels, Koen
    Geesing, Joost M. J.
    Groen, John N.
    ter Borg, Frank
    Wolfhagen, Frank H. J.
    Seldenrijk, Cornelis A.
    Raicu, Mihaela G.
    Milne, Anya N.
    van Lent, Anja U. G.
    Brosens, Lodewijk A. A.
    Johan A. Offerhaus, G.
    Siersema, Peter D.
    Tollenaar, Rob A. E. M.
    Hardwick, James C. H.
    Hawinkels, Lukas J. A. C.
    Moons, Leon M. G.
    Lacle, Miangela M.
    Mesker, Wilma E.
    Boonstra, Jurjen J.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2021, 9 (04) : 478 - 485
  • [27] Reponse to: comment on, ‘Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients’
    C L Downey
    S A Simpkins
    D L Holliday
    J L Jones
    L B Jordan
    J Kulka
    A M Hanby
    V Speirs
    British Journal of Cancer, 2015, 112 : 1833 - 1834
  • [28] Improving Objective Measurements of the Tumour-Stroma Ratio in Breast Cancer Using Polarized Light Microscopy
    Sprenger, Jillian
    Murray, Ciara
    Lad, Jigar
    Jones, Blake
    Thomas, Georgia
    Nofech-Mozes, Sharon
    Khorasani, Mohammadali
    Vitkin, Alex
    ADVANCES IN MICROSCOPIC IMAGING III, 2021, 11922
  • [29] Reponse to: comment on, 'Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'
    Downey, C. L.
    Simpkins, S. A.
    Holliday, D. L.
    Jones, J. L.
    Jordan, L. B.
    Kulka, J.
    Hanby, A. M.
    Speirs, V.
    BRITISH JOURNAL OF CANCER, 2015, 112 (11) : 1833 - 1834
  • [30] The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study
    Liang, Yanting
    Zhu, Yaxi
    Lin, Huan
    Zhang, Shenyan
    Li, Suyun
    Huang, Yanqi
    Liu, Chen
    Qu, Jinrong
    Liang, Changhong
    Zhao, Ke
    Li, Zhenhui
    Liu, Zaiyi
    BMC CANCER, 2021, 21 (01)
12345